Frankfurt Rhine-Main Metropolitan Area
An accomplished, highly seasoned executive with over 25 years of pharmaceutical industry experience and an extensive background in drug development, biologics and specialty pharmaceuticals. A leader with a successful track record in both big pharma and biotech companies to develop corporate strategies and to build highly motivated teams focused on achieving company goals. Outstanding knowledge and proven experience in antibody, protein and small molecule drug early and late stage product development.
• Defining and implementing the product development strategy in oncology • Successful closing of a US $ 32m financing round series A with top tier European and US investors. • Strengthening the management team by hiring CSO, President and CBO and CMO • Building a pipeline of 6 oncology candidates, 2 for own risk development, 4 for partnering • Leading the IND enabling preclinical development of 2 candidates • Successful partnering of preclinical non-oncology programme
• Defining the new strategic direction towards a product development company and leading the implementation • Guiding the company as it refined its product pipeline • Filling key executive positions in Finance, Business Development and Product Development • Implementing a lean and efficient infrastructure for product development and manufacturing • Leading pre-clinical development and GMP production internal product candidates into the clinical phase • Driving clinical development in the EU and US with successful clinical proof-of-concept of the lead candidate • Successful closing of 3 large financing rounds series B and series C with top tier European and US investors with a total volume of US $ 50m. • Successful spin off of antibody discovery into a daughter company; achieved profitability after one year
Business Unit Critical Care
Head of Global Clinical R&D
Head of Clinical R&D